Literature DB >> 16760677

Effect of angiotensin-converting enzyme inhibitors on arterial stiffness in hypertension: systematic review and meta-analysis.

Madhavi Mallareddy1, Chirag R Parikh, Aldo J Peixoto.   

Abstract

Arterial stiffness is an independent cardiovascular prognostic factor and is modulated by angiotensin-converting enzyme inhibitors (ACEIs). The authors performed a meta-analysis of clinical trials investigating the effects of ACEIs on pulse wave velocity (PWV) or augmentation index. The search included randomized clinical trials as well as uncontrolled studies that measured in-treatment changes in arterial stiffness. The authors performed separate analyses for carotid-femoral PWV, brachioradial PWV, and augmentation index. Average absolute and relative reduction in mean arterial pressure and PWV were -15.4 mm Hg and -13.04% and -1.15 m/s and -9.74% for carotid-femoral PWV studies; and -11.2 mm Hg and -9.3% and -1.9 m/s and -16.7% for brachioradial PWV studies. There was a greater reduction in augmentation index by ACEIs when compared with controls (-1.0% to -5.3%). The authors conclude that ACEIs have modest beneficial effects on arterial stiffness measured as PWV and augmentation index, and this effect is at least partly independent of changes in blood pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760677      PMCID: PMC8109373          DOI: 10.1111/j.1076-7460.2006.05418.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  33 in total

Review 1.  Methods and devices for measuring arterial compliance in humans.

Authors:  Bruno M Pannier; Alberto P Avolio; Arnold Hoeks; Giuseppe Mancia; Kenji Takazawa
Journal:  Am J Hypertens       Date:  2002-08       Impact factor: 2.689

Review 2.  Arterial stiffness and function in end-stage renal disease.

Authors:  Gérard M London; Sylvain J Marchais; Alain P Guerin
Journal:  Adv Chronic Kidney Dis       Date:  2004-04       Impact factor: 3.620

3.  Effects of ramipril on arterial hemodynamics.

Authors:  A Benetos; D Vasmant; P Thiéry; M Safar
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

4.  Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors:  A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal:  Control Clin Trials       Date:  1996-02

5.  Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.

Authors:  B M Pannier; A P Guerin; S J Marchais; G M London
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-12       Impact factor: 2.557

6.  Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension.

Authors:  Alison J Deary; Anne L Schumann; Helen Murfet; Stephen Haydock; Roger S Foo; Morris J Brown
Journal:  Clin Sci (Lond)       Date:  2002-11       Impact factor: 6.124

7.  Mechanisms of hypertension after liver transplantation.

Authors:  David A J Neal; Morris J Brown; Ian B Wilkinson; Graeme J M Alexander
Journal:  Transplantation       Date:  2005-04-27       Impact factor: 4.939

8.  Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension.

Authors:  A M Dart; C M Reid; B McGrath
Journal:  Am J Hypertens       Date:  2001-08       Impact factor: 2.689

9.  [Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].

Authors:  Jorge E Toblli; Claudio A Bellido; Oscar R Iavícoli; Marta Costa; Pedro Forcada; Daniel J Piñeiro; Jorge Lerman
Journal:  Medicina (B Aires)       Date:  2002       Impact factor: 0.653

10.  Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.

Authors:  Yves Lacourcière; Richard Béliveau; Howard S Conter; Ellen D Burgess; Serge Lepage; Yves Pesant; J David Spence; Roland Asmar; Serge Carrière; Gérard E Plante
Journal:  Can J Cardiol       Date:  2004-06       Impact factor: 5.223

View more
  16 in total

Review 1.  Applied Healthspan engineering.

Authors:  James W Larrick; Andrew Mendelsohn
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

2.  Altered Aortic Hemodynamics and Relative Pressure in Patients with Dilated Cardiomyopathy.

Authors:  David Marlevi; Jorge Mariscal-Harana; Nicholas S Burris; Julio Sotelo; Bram Ruijsink; Myrianthi Hadjicharalambous; Liya Asner; Eva Sammut; Radomir Chabiniok; Sergio Uribe; Reidar Winter; Pablo Lamata; Jordi Alastruey; David Nordsletten
Journal:  J Cardiovasc Transl Res       Date:  2021-12-09       Impact factor: 4.132

3.  Echo-Doppler assessment of the biophysical properties of the aorta in children with chronic kidney disease.

Authors:  Mohammed Alghamdi; Astrid M De Souza; Colin T White; M Terri Potts; Bradley A Warady; Susan L Furth; Thomas R Kimball; James E Potts; George G S Sandor
Journal:  Pediatr Cardiol       Date:  2013-02-05       Impact factor: 1.655

4.  Angiotensin Receptor Blockades Effect on Peripheral Muscular and Central Aortic Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials and Systematic Review.

Authors:  Chih-Hsuan Yen; Yau-Huei Lai; Chung-Lieh Hung; Ping-Ying Lee; Jen-Yuan Kuo; Hung-I Yeh; Charles Jia-Yin Hou; Kuo-Liong Chien
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

5.  Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients.

Authors:  Balázs Németh; István Kiss; Bella Ajtay; Iván Péter; Zita Kreska; Attila Cziráki; Iván G Horváth; Zénó Ajtay
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

6.  Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association.

Authors:  Raymond R Townsend; Ian B Wilkinson; Ernesto L Schiffrin; Alberto P Avolio; Julio A Chirinos; John R Cockcroft; Kevin S Heffernan; Edward G Lakatta; Carmel M McEniery; Gary F Mitchell; Samer S Najjar; Wilmer W Nichols; Elaine M Urbina; Thomas Weber
Journal:  Hypertension       Date:  2015-07-09       Impact factor: 10.190

7.  Measuring arterial stiffness in clinical practice: Moving one step forward.

Authors:  Hao-Min Cheng; Chen-Huan Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-24       Impact factor: 3.738

8.  Arterial stiffness itself without other inflammatory markers may not provide information to clinicians.

Authors:  Sevket Balta; Mustafa Cakar; Sait Demirkol; Murat Unlu; Ugur Kucuk; Zekeriya Arslan
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738

9.  Pulse wave velocity in white coat and masked hypertension.

Authors:  Sante D Pierdomenico; Francesca Coccina; Rosalinda Madonna
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-30       Impact factor: 3.738

10.  Genetic variation in CYP17A1 is associated with arterial stiffness in diabetic subjects.

Authors:  Soo Jin Yang; Seung-Tae Lee; Won Jun Kim; Se Eun Park; Sung Woo Park; Jong-Won Kim; Cheol-Young Park
Journal:  Exp Diabetes Res       Date:  2012-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.